These clinical manifestations emphasized a predominant role for OSM in the differentiation of erythrocytes, platelets and, to a lesser extent, granulocytes, an observation consistent with the finding that healthy individuals injected with high doses of neutralizing anti-OSM antibodies exhibited mild anemia and thrombocytopenia (39). This evidence concerns the gene OSM and anemia.